Studying the blood–brain barrier will provide new insights into neurodegeneration – Yes

Neurological disorders are the third leading cause of mortality, morbidity, and disability throughout the world and impose a significant burden on society and healthcare budgets in Western European countries. Current medication regimes of neurological disorders have disappointing results and may lead to severe side effects. Therefore, the need to develop new ways to treat or even cure and/or prevent these neurological disorders is high.

• Publication year

  2018

• Venue

  Multiple Sclerosis

• Publication date

  2018-03-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/1352458518754367PMID 29504448PMCID 6029146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia

  2017cited by this paper
• Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.

  2016cited by this paper
• Internalization and presentation of myelin antigens by the brain endothelium guides antigen-specific T cell migration

  2016cited by this paper
• Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis.

  2011cited by this paper
• Amyloid Beta Induces Oxidative Stress-Mediated Blood–Brain Barrier Changes in Capillary Amyloid Angiopathy

  2011cited by this paper
• Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein.

  2008cited by this paper
• Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes

  2007cited by this paper
• Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex.

  2007cited by this paper
• Persistent endothelial abnormalities and blood–brain barrier leak in primary and secondary progressive multiple sclerosis

  2007cited by this paper
• Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.

  2005cited by this paper
• Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study.

  2004cited by this paper

• Trans-10-hydroxy-2-decenoic acid alleviates LPS-induced blood-brain barrier dysfunction by activating the AMPK/PI3K/AKT pathway.

  2019cites this paper